BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 16358332)

  • 1. Low mRNA levels of RGS4 splice variants in Alzheimer's disease: association between a rare haplotype and decreased mRNA expression.
    Emilsson L; Saetre P; Jazin E
    Synapse; 2006 Mar; 59(3):173-6. PubMed ID: 16358332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Full length cloning and expression analysis of splice variants of regulator of G-protein signaling RGS4 in human and murine brain.
    Ding L; Mychaleckyj JC; Hegde AN
    Gene; 2007 Oct; 401(1-2):46-60. PubMed ID: 17707117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of RGS4 splice variants in dorsolateral prefrontal cortex of schizophrenic and bipolar disorder patients.
    Ding L; Hegde AN
    Biol Psychiatry; 2009 Mar; 65(6):541-5. PubMed ID: 19041089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in regional and subcellular localization of G(q/11) and RGS4 protein levels in Alzheimer's disease: correlation with muscarinic M1 receptor binding parameters.
    Muma NA; Mariyappa R; Williams K; Lee JM
    Synapse; 2003 Jan; 47(1):58-65. PubMed ID: 12422374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulator of G-protein signalling 4 expression is not altered in the prefrontal cortex in schizophrenia.
    Stuart Gibbons A; Scarr E; McOmish CE; Hannan AJ; Thomas EA; Dean B
    Aust N Z J Psychiatry; 2008 Aug; 42(8):740-5. PubMed ID: 18622782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional alterations in RGS4 protein in schizophrenia.
    Erdely HA; Tamminga CA; Roberts RC; Vogel MW
    Synapse; 2006 Jun; 59(8):472-9. PubMed ID: 16565965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
    Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
    BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia.
    Mirnics K; Middleton FA; Stanwood GD; Lewis DA; Levitt P
    Mol Psychiatry; 2001 May; 6(3):293-301. PubMed ID: 11326297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional expression of RGS4 mRNA in human brain.
    Erdely HA; Lahti RA; Lopez MB; Myers CS; Roberts RC; Tamminga CA; Vogel MW
    Eur J Neurosci; 2004 Jun; 19(11):3125-8. PubMed ID: 15182322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rgs4 mRNA expression is decreased in the brain of Fmr1 knockout mouse.
    Tervonen T; Akerman K; Oostra BA; Castrén M
    Brain Res Mol Brain Res; 2005 Jan; 133(1):162-5. PubMed ID: 15661377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute amphetamine down-regulates RGS4 mRNA and protein expression in rat forebrain: distinct roles of D1 and D2 dopamine receptors.
    Schwendt M; Gold SJ; McGinty JF
    J Neurochem; 2006 Mar; 96(6):1606-15. PubMed ID: 16539683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease: mRNA expression profiles of multiple patients show alterations of genes involved with calcium signaling.
    Emilsson L; Saetre P; Jazin E
    Neurobiol Dis; 2006 Mar; 21(3):618-25. PubMed ID: 16257224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RCAN1-1L is overexpressed in neurons of Alzheimer's disease patients.
    Harris CD; Ermak G; Davies KJ
    FEBS J; 2007 Apr; 274(7):1715-24. PubMed ID: 17331188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurexin 3 polymorphisms are associated with alcohol dependence and altered expression of specific isoforms.
    Hishimoto A; Liu QR; Drgon T; Pletnikova O; Walther D; Zhu XG; Troncoso JC; Uhl GR
    Hum Mol Genet; 2007 Dec; 16(23):2880-91. PubMed ID: 17804423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single molecule profiling of tau gene expression in Alzheimer's disease.
    Conrad C; Zhu J; Conrad C; Schoenfeld D; Fang Z; Ingelsson M; Stamm S; Church G; Hyman BT
    J Neurochem; 2007 Nov; 103(3):1228-36. PubMed ID: 17727636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tau and saitohin gene expression pattern in progressive supranuclear palsy.
    Ezquerra M; Gaig C; Ascaso C; Muñoz E; Tolosa E
    Brain Res; 2007 May; 1145():168-76. PubMed ID: 17320831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased alternative splicing of estrogen receptor-α mRNA in the Alzheimer's disease brain.
    Ishunina TA; Swaab DF
    Neurobiol Aging; 2012 Feb; 33(2):286-296.e3. PubMed ID: 20417581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S1P receptor signalling and RGS proteins; expression and function in vascular smooth muscle cells and transfected CHO cells.
    Hendriks-Balk MC; van Loenen PB; Hajji N; Michel MC; Peters SL; Alewijnse AE
    Eur J Pharmacol; 2008 Dec; 600(1-3):1-9. PubMed ID: 18854184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamin-binding protein gene on chromosome 10q is associated with late-onset Alzheimer's disease.
    Kuwano R; Miyashita A; Arai H; Asada T; Imagawa M; Shoji M; Higuchi S; Urakami K; Kakita A; Takahashi H; Tsukie T; Toyabe S; Akazawa K; Kanazawa I; Ihara Y;
    Hum Mol Genet; 2006 Jul; 15(13):2170-82. PubMed ID: 16740596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-terminal residues control proteasomal degradation of RGS2, RGS4, and RGS5 in human embryonic kidney 293 cells.
    Bodenstein J; Sunahara RK; Neubig RR
    Mol Pharmacol; 2007 Apr; 71(4):1040-50. PubMed ID: 17220356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.